As of 1:48:00 PM EST. Market Open.
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 0.25 | 0.27 | 0.99 | 1.06 |
| Low Estimate | 0.25 | 0.27 | 0.99 | 1.06 |
| High Estimate | 0.25 | 0.27 | 0.99 | 1.06 |
| Year Ago EPS | 0.21 | 0.25 | 0.82 | 0.99 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 570M | 646M | 2.26B | 2.49B |
| Low Estimate | 570M | 646M | 2.26B | 2.49B |
| High Estimate | 570M | 646M | 2.26B | 2.49B |
| Year Ago Sales | 516.76M | 578.61M | 2.03B | 2.26B |
| Sales Growth (year/est) | 10.30% | 11.65% | 11.61% | 10.18% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | 0.2 | 0.25 | 0.23 | 0.23 |
| EPS Actual | 0.21 | 0.25 | 0.23 | 0.26 |
| Difference | 0.01 | 0 | 0 | 0.03 |
| Surprise % | 5.00% | 0.00% | 0.00% | 13.04% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0.25 | 0.27 | 0.99 | 1.06 |
| 7 Days Ago | 0.25 | 0.28 | 0.99 | 1.06 |
| 30 Days Ago | 0.25 | 0.28 | 0.99 | 1.06 |
| 60 Days Ago | 0.25 | 0.28 | 0.99 | 1.06 |
| 90 Days Ago | 0.22 | 0.27 | 0.93 | 0.99 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | 1 | 1 | 1 | 1 |
| Up Last 30 Days | 1 | 1 | 1 | 1 |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| BGC | 19.05% | 8.00% | 20.73% | 7.07% |
| S&P 500 | 5.00% | 12.00% | 2.10% | 12.20% |
Upgrades & Downgrades
| Maintains | Piper Sandler: Overweight to Overweight | 11/1/2024 |
| Reiterates | Piper Sandler: Overweight to Overweight | 9/12/2024 |
| Reiterates | Piper Sandler: Overweight to Overweight | 7/31/2024 |
| Reiterates | Piper Sandler: Overweight to Overweight | 7/1/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 5/6/2024 |
| Maintains | Piper Sandler: Overweight to Overweight | 4/12/2024 |
Related Tickers
NMR Nomura Holdings, Inc.
5.85
+0.95%
PJT PJT Partners Inc.
156.61
-0.76%
SF-PB Stifel Financial Corp.
24.55
+0.61%
PIPR Piper Sandler Companies
298.03
-0.64%
VIRT Virtu Financial, Inc.
36.06
+1.07%
TOP TOP Financial Group Limited
1.5101
-1.30%
GS-PC The Goldman Sachs Group, Inc. PFD 1/1000 C
24.06
-0.72%
SNEX StoneX Group Inc.
99.11
+1.16%
MC Moelis & Company
73.72
-0.22%
MS-PE Morgan Stanley
25.28
+0.18%